Literature DB >> 16677176

Predisposition of antituberculosis drug induced hepatotoxicity by cytochrome P450 2E1 genotype and haplotype in pediatric patients.

Bidyut Roy, Sanat Kumar Ghosh, Debabrata Sutradhar, Nilabja Sikdar, Santasree Mazumder, Santanu Barman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16677176     DOI： 10.1111/j.1440-1746.2006.04197.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  17 in total

Review 1.  Pharmacogenomics of antimicrobial agents.

Authors:  Ar Kar Aung; David W Haas; Todd Hulgan; Elizabeth J Phillips
Journal:  Pharmacogenomics       Date:  2014       Impact factor: 2.533

2.  PharmGKB summary: isoniazid pathway, pharmacokinetics.

Authors:  Daniel J Klein; Sotiria Boukouvala; Ellen M McDonagh; Scott R Shuldiner; Nicola Laurieri; Caroline F Thorn; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2016-09       Impact factor: 2.089

3.  Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.

Authors:  Shuangyu Yang; Xia Dou; Zhen Wang; Wenjie Zhang; Kefan Ding; Wenting Meng; Haiyue Li; Jianfeng Liu; Yuanwei Liu; Tianbo Jin
Journal:  Mol Genet Genomics       Date:  2022-02-11       Impact factor: 3.291

Review 4.  PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Authors:  Ellen M McDonagh; Sotiria Boukouvala; Eleni Aklillu; David W Hein; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-08       Impact factor: 2.089

Review 5.  A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?

Authors:  Lorena Baietto; Silvia Corcione; Giovanni Pacini; Giovanni Di Perri; Antonio D'Avolio; Francesco Giuseppe De Rosa
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731

Review 6.  Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives.

Authors:  Laurent Abel; Jacques Fellay; David W Haas; Erwin Schurr; Geetha Srikrishna; Michael Urbanowski; Nimisha Chaturvedi; Sudha Srinivasan; Daniel H Johnson; William R Bishai
Journal:  Lancet Infect Dis       Date:  2017-10-27       Impact factor: 25.071

7.  Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort.

Authors:  Shaowen Tang; Xiaozhen Lv; Yuan Zhang; Shanshan Wu; Zhirong Yang; Yinyin Xia; Dehua Tu; Peiyuan Deng; Yu Ma; Dafang Chen; Siyan Zhan
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

8.  Role of pharmacogenomics in the treatment of tuberculosis: a review.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Pharmgenomics Pers Med       Date:  2012-09-13

9.  Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.

Authors:  Yu Cai; JiaYong Yi; ChaoHui Zhou; XiZhong Shen
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition.

Authors:  Nicholas E Thomford; Kevin Dzobo; Denis Chopera; Ambroise Wonkam; Michelle Skelton; Dee Blackhurst; Shadreck Chirikure; Collet Dandara
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.